GSK’s Pivotal Test for mRNA Vaccine Aims to Show Two Targets Are Better Than OneNews DeskSeptember 1, 20260 With respiratory virus season approaching, GSK is preparing to begin a Phase 3 clinical trial evaluating its experimental messenger RNA…